| Product Name | MF | CAS | Details |
|---|
| Lisinopril impurity 3/Lisinopril EP Impurity D/R,S,S-Diketopiperazine | C21H29N3O4 | 219677-82-4 | Details |
| Pramipexole impurity 4/Pramipexole EP Impurity D/Dexpramipexole | C10H17N3S | 104632-28-2 | Details |
| Aprepitant impurity 17 | C20H16F7NO3 | 419574-33-7 | Details |
| Aprepitant impurity 12 | C20H18F7NO2 | 380499-06-9 | Details |
| Quetiapine EP Impurity P 2HCl | C19H21N3S | 1011758-03-4 | Details |
| Zolmitriptan EP Impurity C/Zolmitriptan USP Related Compound F/Zolmitriptan Dimer Impurity | C38H53N7O4 | 1350928-05-0 | Details |
| 4-(2-fluoro-4-nitrophenyl)-1-methyl-1,4,5,6-tetrahydro-1,2,4-triazine | C10H11FN4O2 | 1334167-66-6 | Details |
| Zolmitriptan EP Impurity B/Zolmitriptan N-Oxide/Zolmitriptan USP Related Compound E | C16H21N3O3 | 251451-30-6 | Details |
| Aprepitant impurity 15 | C20H18F7NO2 | 327623-37-0 | Details |
| Quetiapine DBTO Sulfone | C13H9NO3S | 22871-33-6 | Details |
| Pitavastatin impurity 2/(3S,5R)-Pitavastatin Calcium Salt | C25H26CaFNO4 | 254452-88-5 | Details |
| Pitavastatin Impurity/tert-butyl 2-((4S,6S)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl)acetate | C25H22FNO3 | 1422058-54-5 | Details |
| Aprepitant impurity 16 | C20H18F7NO2 | 1242175-38-7 | Details |
| Quetiapine DBTP 7-Hydroxy Metabolite/7-Hydroxy N-Desalkyl Quetiapine | C17H17N3OS | 232597-73-8 | Details |
| Quetiapine EP Impurity U/Dibenzo[b,f][1,4]thiazepin-11-amine | C13H10N2S | 5786-26-5 | Details |
| 4-amino-N-hydroxy-furazan-3-carboxamidine | C3H5N5O2 | 13490-32-9 | Details |
| 3-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridine | C7H4F3N3 | 956010-87-0 | Details |
| Famotidine EP Impurity C HCl | C8H15ClN6O3S3 | 76824-17-4 | Details |
| Aprepitant impurity 1/Aprepitant EP Impurity A /Defluoro Aprepitant | C23H22F6N4O3 | 170729-76-7 | Details |
| Clavulanate Potassium impurity 1/Potassium Clavulanate EP Impurity A/2,5-Pyrazinediethanol | C8H12N2O2 | 4744-51-8 | Details |
| Pitavastatin impurity 7/Desfluoro Pitavastatin Calcium Salt | C50H50CaN2O8 | 1258947-30-6 | Details |
| Quetiapine EP Impurity K | C23H29N3O4S | 1371638-10-6 | Details |
| 3-(4-Amino-1,2,5-oxadiazol-3-yl)-4-(3-bromo-4-fluorophenyl)-1,2,4-oxadiazol-5(4H)-one | C10H5BrFN5O3 | 914471-43-5 | Details |
| Quetiapine EP Impurity W/O-Dibenzo[b,f][1,4]thiazepinyl Quetiapine | C34H32N4O2S2 | 1800608-95-0 | Details |
| N-tritylethanolamine | C21H21NO | 24070-16-4 | Details |
| Aprepitant impurity 7/(1R,2S,3S)-Aprepitant | C23H21F7N4O3 | 172822-28-5 | Details |
| 4-[(6,7-dimethoxyquinolin-4-yl)oxy]-3-fluoroaniline | C17H15FN2O3 | 347161-74-4 | Details |
| Famotidine EP Impurity B | C16H23N11O2S5 | 89268-62-2 | Details |
| Lisinopril impurity 2/Lisinopril EP impurity C/S,S,S-Diketopiperazine | C21H29N3O4 | 328385-86-0 | Details |
| Citalopram impurity 5/Citalopram N-Oxide/Escitalopram EP Impurity H | C20H21FN2O2 | 63284-72-0 | Details |
| Pramipexole impurity 3/Pramipexole EP Impurity B/2-N-Propyl Pramipexole | C13H23N3S | 1246815-83-7 | Details |
| Aprepitant impurity 5/Aprepitant EP Impurity E | C23H21F7N4O3 | 1148113-53-4 | Details |
| Ramipril EP Impurity C | C23H38N2O5 | 99742-35-5 | Details |
| Quetiapine EP Impurity E/Quetiapine bis-Ether | C40H44N6O2S2 | 1371638-05-9 | Details |
| Pramipexole impurity 6/Pramipexole Ethylamino Analog/ Ethyl Pramipexole | C9H15N3S | 1254579-15-1 | Details |
| Pitavastatin impurity 6/(Z)-Pitavastatin Calcium Salt | C25H26CaFNO4 | 1159588-21-2 | Details |
| Quetiapine EP Impurity N/Quetiapine Dipiperazine Diether Impurity | C29H41N5O3S | 1800291-86-4 | Details |
| Clavulanate Potassium impurity 3/Clavulanate Potassium EP Impurity G | C13H15NO6 | 374816-32-7 | Details |
| Darifenacin impurity 2/2,3-Dehydro Darifenacin HBr | C28H29BrN2O2 | 943034-52-4 | Details |
| Darifenacin impurity 1/(R)-Darifenacin HBr/ent-Darifenacin HBr | C28H31BrN2O2 | 1092800-15-1 | Details |
| Pitavastatin impurity 3/(3S,5S)-Pitavastatin Calcium Salt | C25H26CaFNO4 | 254452-92-1 | Details |
| Aprepitant impurity 20/Fosaprepitant Morpholine | C20H18F7NO2 | 170902-80-4 | Details |
| Pramipexole impurity 8/Pramipexole (7R)-Hydroxy Impurity/Pramipexole USP Related Compound F | C10H17N3OS | 2166216-34-6 | Details |
| Pramipexole impurity 7/Pramipexole N2-Propionyl Impurity | C13H21N3OS | 1801892-43-2 | Details |
| Sivelestat sodium | C20H25N2NaO8S | 201677-61-4 | Details |
| Aprepitant impurity 14 | C20H18F7NO2 | 170729-79-0 | Details |
| Ketorolac impurity 1/Ketorolac R-Isomer | C15H13NO3 | 66635-93-6 | Details |
| Pitavastatin Impurity 11 | C25H24FNO4.C8H11N | 147511-70-4 | Details |
| Pramipexole impurity 9/Pramipexole (7S)-Hydroxy Impurity/Pramipexole USP Related Compound G | C10H17N3OS | 1001648-71-0 | Details |
| Pramipexole impurity 2/Pramipexole Di-Amide | C13H19N3O2S | 1346617-47-7 | Details |
| Orlistat impurity 5/Orlistat USP Related Compound E/L-Isoleucine Orlistat | C29H53NO5 | 1072902-75-0 | Details |
| N-(4-methyl-3-nitrophenyl)-3-(trifluoromethyl)benzamide | C15H11F3N2O3 | 221876-21-7 | Details |
| Aprepitant impurity 13 | C20H18F7NO2 | 1185503-48-3 | Details |
| Quetiapine EP Impurity J/Quetiapine Hydroxyethyloxyethyl Ether | C25H33N3O4S | 1356906-17-6 | Details |
| Aprepitant impurity 6/(1R,2S,3R)-Aprepitant | C23H21F7N4O3 | 1185502-97-9 | Details |
| Carbamic acid, [2-[(5-isoquinolinylsulfonyl)amino]ethyl]-, 1,1-dimethylethyl ester (9CI) | C16H21N3O4S | 651309-72-7 | Details |
| Aprepitant impurity 22/Aprepitant Open-Ring Methyl Ester Impurity | C24H25F7N4O4 | 219821-37-1 | Details |
| BisphenolA(3-chloro-2-hydroxypropyl)GlycidylEther | C21H25ClO4 | 13836-48-1 | Details |
| Clavulanate Potassium impurity 2/Clavulanate Potassium EP Impurity D | C7H9NO3 | 404839-11-8 | Details |
| 7-Hydroxy Quetiapine Sulfoxide/Quetiapine Sulfoxide 7-Hydroxy Metabolite | C21H25N3O4S | 1185170-04-0 | Details |
| (S)-Ketorolac | C15H13NO3 | 66635-92-5 | Details |
| 1H-Pyrazolo[3,4-b]pyridine-3-carbonitrile | C7H4N4 | 956010-88-1 | Details |
| Pitavastatin Impurity 10 | C25H23FNNaO4 | 574705-92-3 | Details |
| Famotidine EP Impurity F | C8H12N4O2S2 | 107880-74-0 | Details |
| Pitavastatin impurity 1/(3R, 5R)-Pitavastatin Calcium Salt | C25H24FNO4 | 254452-96-5 | Details |
| Quetiapine EP Impurity T/Quetiapine Morpholine Impurity | C17H16N2OS | 5747-46-6 | Details |
| Quetiapine EP Impurity O/O-Triphenylmethoxy Quetiapine | C40H39N3O2S | 844639-06-1 | Details |
| Aprepitant impurity 10/(S,S,S)-Aprepitant | C23H21F7N4O3 | 1242175-40-1 | Details |
| Aprepitant impurity 21/Aprepitant N-Oxide | C23H21F7N4O4 | 172673-23-3 | Details |
| 1334167-59-7 | C9H11FN2O5S | 1334167-59-7 | Details |
| Quetiapine EP Impurity H/Quetiapine N-Oxide | C21H25N3O3S | 1076199-40-0 | Details |
| Aprepitant impurity 18 | C20H16F7NO3 | 419574-04-2 | Details |
| Orlistat impurity 1/Orlistat Dihydro Pyranone Impurity | C22H40O2 | 130676-64-1 | Details |
| Quetiapine EP Impurity I/Quetiapine Hydroxy Impurit | C19H21N3OS | 329216-67-3 | Details |
| Ritonavir EP Impurity H/Des(isopropylthiazolyl) Hydantoin-oxazolidinone Ritonavir | C30H32N4O6S | 1010809-43-4 | Details |
| Aprepitant impurity 4/Aprepitant EP Impurity D/ent-Aprepitant | C23H21F7N4O3 | 172822-29-6 | Details |
| Quetiapine EP Impurity A | C23H27N3O3S | 844639-07-2 | Details |
| Quetiapine EP Impurity L/9-Chloro Quetiapine | C21H24ClN3O2S | 1371638-11-7 | Details |
| Quetiapine EP Impurity C | C40H42N6O3S2 | 1798840-31-9 | Details |
| Aprepitant impurity 11 | C20H19ClF7NO2 | 1447693-83-5 | Details |
| Quetiapine EP Impurity S/Quetiapine Sulfoxide | C21H25N3O3S | 329216-63-9 | Details |
| N-(3-amino-4-methylphenyl)-3-(trifluoromethyl)benzamide | C15H13F3N2O | 30069-31-9 | Details |
| Quetiapine EP Impurity D/ Quetiapine Dimer Impurity/Quetiapine Bis(dibenzothiazepinyl) piperazine Impurity(USP) | C30H24N4S2 | 945668-94-0 | Details |
| Orlistat impurity 4/Orlistat USP Related Compound D | C29H53NO5 | 130793-27-0 | Details |
| 2,2,2-trifluoro-1-(2-fluoropyridin-3-yl)ethan-1-one | C7H3F4NO | 1186608-79-6 | Details |
| Quetiapine Sulfone HCl | C25H18N2S2 | 2206135-50-2 | Details |
| Quetiapine EP Impurity F | C21H27N3O3S | 848814-27-7 | Details |
| Aprepitant impurity 8/(1S,2R,3R)-Aprepitant | C23H21F7N4O3 | 1242175-34-3 | Details |
| 2-(6-Chloro-2-methylpyrimidin-4-ylamino)thiazole-5-carboxylic acid ethyl ester | C11H11ClN4O2S | 1202357-66-1 | Details |
| Quetiapine DBTP N-Methyl Impurity | C18H19N3S | 1977-09-9 | Details |
| Aprepitant impurity 19 | C20H18F7NO2 | 1242175-36-5 | Details |
| Pitavastatin Impurity 9 | C25H20FNO2 | 148516-15-8 | Details |
| Citalopram impurity 4/Citalopram EP Impurity D HCl/(S)-N-Desmethyl Citalopram Hydrochloride | C19H19FN2O | 144025-14-9 | Details |
| Lisinopril impurity 4/Lisinopril EP Impurity E/Lisinopril Epimer | C21H31N3O5 | 85955-59-5 | Details |
| Orlistat impurity 2/Orlistat USP Related Compound A | C22H42O3 | 104872-06-2 | Details |
| Famotidine EP Impurity D | C8H13N5OS2 | 76824-16-3 | Details |
| 2-((6-Chloro-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxylic acid | C9H7ClN4O2S | 1251716-89-8 | Details |
| Pramipexole impurity 1/Pramipexole 7-Oxo Impurity | C10H15N3OS | 1286047-33-3 | Details |
| Quetiapine EP Impurity V | C21H25N3O2 | 2204369-14-0 | Details |
| Aprepitant impurity 9/(1S,2R,3S)-Aprepitant | C23H21F7N4O3 | 170902-81-5 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 | ||||